DNA Biomed Solns (DNA) — Long-term Investment Intensity
DNA Biomed Solns (DNA) has a Long-term Investment Intensity of 98.7% as of June 2019. Long-term investments of ILA51.99 Million represent 98.7% of total assets of ILA52.70 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check DNA Biomed Solns cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
DNA Biomed Solns Long-term Investment Intensity (2013–2018)
This chart shows how DNA Biomed Solns's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 98.7%, reflecting long-term investments of ILA51.99 Million against total assets of ILA52.70 Million ILA. Explore cash flow to debt ratio of DNA Biomed Solns to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for DNA Biomed Solns (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for DNA Biomed Solns from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see DNA company net worth.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 99.4% | ILA80.20 Million | ILA80.72 Million | ▲ +1.4 pp |
| 2017 | 97.9% | ILA76.49 Million | ILA78.09 Million | ▲ +81.5 pp |
| 2016 | 16.4% | ILA6.28 Million | ILA38.17 Million | ▼ -6.0 pp |
| 2015 | 22.4% | ILA6.22 Million | ILA27.75 Million | ▼ -11.3 pp |
| 2014 | 33.8% | ILA6.52 Million | ILA19.32 Million | ▲ +6.5 pp |
| 2013 | 27.3% | ILA5.64 Million | ILA20.68 Million | — |